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Abstract
MicroRNAs (miRNAs) are small non-coding RNAs, that play important regulatory roles in a variety of biological processes,
including development, differentiation, apoptosis, and metabolism. In mammals, miRNAs have been shown to modulate
adipocyte differentiation. Therefore, we performed a global miRNA gene expression assay in different fat depots of
overweight and obese individuals to investigate whether miRNA expression in human adipose tissue is fat-depot specific
and associated with parameters of obesity and glucose metabolism. Paired samples of abdominal subcutaneous (SC) and
intraabdominal omental adipose tissue were obtained from fifteen individuals with either normal glucose tolerance (NGT,
n=9) or newly diagnosed type 2 diabetes (T2D, n=6). Expression of 155 miRNAs was carried out using the
TaqManHMicroRNA Assays Human Panel Early Access Kit (Applied Biosystems, Darmstadt, Germany). We identified
expression of 106 (68%) miRNAs in human omental and SC adipose tissue. There was no miRNA exclusively expressed in
either fat depot, suggesting common developmental origin of both fat depots. Sixteen miRNAs (4 in NGT, 12 in T2D group)
showed a significant fat depot specific expression pattern. We identified significant correlations between the expression of
miRNA-17-5p, -132, -99a, -134, 181a, -145, -197 and both adipose tissue morphology and key metabolic parameters,
including visceral fat area, HbA1c, fasting plasma glucose, and circulating leptin, adiponectin, interleukin-6. In conclusion,
microRNA expression differences may contribute to intrinsic differences between omental and subcutaneous adipose tissue.
In addition, human adipose tissue miRNA expression correlates with adipocyte phenotype, parameters of obesity and
glucose metabolism.
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Introduction
MicroRNAs (miRNAs) are small (21–25 nucleotides in length),
non-coding RNAs, that play an important regulatory role in
animals and plants by targeting mRNA transcripts for cleavage or
translational repression [1–3]. More than 900 unique mature
miRNAs have been identified across species and their expression
levels vary among species and tissues [4]. Following the discovery
of the first miRNA in 1993, the important roles of miRNAs in a
variety of biological processes, including development, differenti-
ation, apoptosis, lipid metabolism, and cancer have been
discovered [5]. In mammals, miRNAs have been shown to
modulate stem cell and adipocyte differentiation as well as insulin
secretion [6–8]. Esau et al. [9] found that reducing miRNA-143 by
transfecting antisense oligonucleotides inhibits adipocyte differen-
tiation in vitro, suggesting that miRNAs may play a role in the
regulation of key adipose tissue processes and could therefore
represent novel targets for the treatment of obesity. In addition,
miRNAs have been shown to regulate metabolic processes, which
are associated with type 2 diabetes including insulin signaling and
glucose homeostasis [6,10].
To gain further insight into the association between miRNA
expression in human adipose tissue and parameters of obesity, fat
distribution and glucose metabolism, we performed a global
miRNA gene expression array in paired omental and abdominal
subcutaneous adipose tissue samples from fifteen overweight or
obese individuals with either normal glucose tolerance or type 2
diabetes. We tested the hypotheses that miRNA expression in
human adipose tissue is fat-depot specific and related to




The study was approved by the Ethics Committee of the
University of Leipzig. All subjects gave written informed consent
before taking part in the study.
Subjects
Paired samples of abdominal subcutaneous and intraabdominal
omental adipose tissue were obtained from fifteen Caucasian men
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4699(n=8) and women (n=7) who underwent open abdominal surgery
for elective cholecystectomy or explorative laparotomy. The age
ranged from 50 to 73 years and the body mass index from 25.4 to
38.1 kg/m
2. In addition to 9 patients with normal glucose
tolerance (NGT), we newly diagnosed 6 individuals with type 2
diabetes (T2D). All subjects had a stable weight with no
fluctuations of more than 2% of the body weight for at least three
months before surgery. Only individuals, which fulfilled the
previously reported inclusion criteria have included in the study
[11–13]. Samples of omental and subcutaneous adipose tissue
were immediately frozen in liquid nitrogen after explantation.
Body mass index (BMI) was calculated as weight divided by
squared height. Waist and hip circumferences were measured and
waist-to-hip ratio was calculated. Percentage body fat was
measured by dual X-ray absorptiometry (DEXA). Abdominal
visceral and subcutaneous fat areas were calculated by CT scans
measurement (L4–L5) [11–13].
Assays and euglycemic–hyperinsulinemic clamp
Oral glucose tolerance test (OGTT) was performed according to
the criteria of the American Diabetes Association (ADA) [14].
Blood samples were taken after an overnight fast to determine
glucose, insulin, lipids and other standard laboratory parameters.
Plasma insulin was measured using the IMMULITE automated
analyzer (Diagnostic Products, Los Angeles, CA, USA). Leptin was
measured with an ELISA (Mediagnost, Reutlingen, Germany).
Plasma adiponectin was quantified with an ELISA (AdipoGen;
Inc.; Seoul, South Korea). Serum C-reactive protein (CRP;
immunoturbidometric latex test) and lipid analysis were performed
with the ModularAnalytics EVO System (Roche Diagnostics
GmbH, Mannheim, Germany). A high-sensitivity ELISA was used
for IL-6 measurement (Quantikine IL-6, R&D Systems, Oxford,
UK). Insulin sensitivity was assessed with the euglycemic-
hyperinsulinemic clamp method, as described previously [15,16].
Characterization of adipose tissue morphology
For adipocyte size distribution analyses, adipocytes were
isolated by collagenase (1 mg/ml) digestion. Aliquots of adipocytes
were fixed with osmic acid and counted in triplicate using
Multisizer III (Beckman-Coulter, Hamburg, Germany). For
morphology studies, tissue samples were fixed in 10% buffered
formalin and imbedded in paraffin. Multiple sections were
analyzed systematically with respect to adipocyte size, number
and macrophage number as previously described [17]. In brief,
five micrometer sections were mounted on glass slides, de-
paraffinized in Xylol and stained for CD68 using anti-CD68
monoclonal mouse anti-human antibody (Dako, close PGM1
M0876, dilution 1:100), using standard immunohistochemistry
methods. Macrophages were identified in the adipose parenchyma
(CD68 within blood vessels were excluded), when cytoplasmic
staining for CD68 was present along with an identifiable
mononuclear nucleus, and presented as the number per 100
adipocytes (% macrophages) or as number of cells per 126400
fields, as indicated. Staining of the sections was performed with
hematoxylin and eosin. Images were acquired using BX60
microscope (Olympus) and were analyzed using Image-Pro Plus
4.0 software.
Analysis of human adipose tissue miRNA gene
expression
Human miRNA gene expression was performed with the
TaqManHMicroRNA Assays Human Panel Early Access Kit
(Applied Biosystems, Darmstadt, Germany). Fluorescence was
detected on an ABI PRISM 7700 sequence detector (Applied
Biosystems, Darmstadt, Germany) using FAM as fluorescent
reporter. Total RNA was isolated from paired subcutaneous and
omental adipose tissue samples using TRIzol (Life Technologies,
Grand Island, NY). cDNA was reversely transcribed from 5 ng
total RNA samples using specific miRNA stem-loop primers from
the TaqManHMicroRNA Assays Human Panel. PCR products
were synthesized from cDNA samples using sequence-specific
primers from the TaqManHMicroRNA Assays Human Panel
(Applied Biosystems, Darmstadt, Germany).
Using the comparative CT method, hsa-miR-16 served as
endogenous controls to normalize the expression levels of miRNA
target genes by correcting differences in the amount of cDNA
loaded into PCR reactions. Three Caenorhabditis elegans miRNAs,
cel-lin-4, cel-miR-2, and cel-miR-124, and Arabidopsis miRNA,
ath-miR-159a, served as negative controls. These four microRNAs
were not detectable in the presence of human total RNA samples.
Statistical analyses
Data are shown as means6standard errors of the mean (SEM)
unless stated otherwise. Before statistical analysis, non-normally
distributed parameters were logarithmically transformed to
approximate a normal distribution. The following statistical tests
were used: paired Student’s t test and Pearson’s simple correlation.
Linear relationships were assessed by least square regression
analysis. Statistical analysis was performed using SPSS version
12.0 (Chicago, IL). P values,0.05 were considered to be
statistically significant. Since multiple statistical tests have been
applied we performed additional Bonferroni correction for
multiple comparisons, after which a p-value,0.001 was consid-
ered statistically significant.
Results
Human adipose tissue miRNA expression
Anthropometric and metabolic characteristics of study partic-
ipants are summarized in Table 1. Gene expression analysis of 155
miRNAs in human paired omental and SC adipose tissue samples
revealed that 106 (68%) out of 155 miRNAs are detectable in both
omental and SC fat samples. There was no miRNA exclusively
expressed in either fat depot. However, we found significant
miRNA expression differences between omental and SC adipose
tissue (Table 2). Interestingly, the miRNA expression pattern was
different in NGT as compared to T2D patients (Table 2). In
addition, we found significantly higher expression of miR-17-5p,
miR-132, miR-134 in omental fat of NGT compared to T2D,
whereas the opposite pattern was found for miR-181a. In SC fat,
expression of miR-27a, miR-30e, miR-140, miR-155, miR-210
was significantly higher and expression of miR-147 and miR-197
was lower in NGT as compared to the T2D group
Expression of selected miRNAs in adipose tissue
correlates with parameters of obesity, metabolism, and
morphology of adipose tissue
We further tested the hypothesis that expression of miRNAs is
related to adipose tissue and adipocyte phenotype, parameters of
obesity and glucose metabolism by univariate regression analyses.
We identified six miRNAs in omental (Table 3) and four miRNAs
in SC fat, which are significantly associated with adipose tissue
morphology, parameters of obesity, glucose and lipid metabolism.
Visceral fat area was negatively associated with the expression of
miR-17-5p and miR-132 (Table 3). In SC fat, BMI is significantly
correlated with the expression of miR-34a (r=20.71, p=0.004)
and miR-145 (r=0.53, p,0.05). In addition to the significant
MicroRNA in Adipose Tissue
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expression of selected miRNAs in visceral adipose tissue (Table 3),
we identified significant correlations between SC fat expression of
miR-145, HDL-cholesterol (r=20.63, p,0.01), and 2-hour
OGTT glucose levels (r=0.93, p,0.01). miR-197 expression in
SC fat correlates with fasting plasma glucose (r=0.7, p=0.004)
and glucose infusion rate during in the clamp (r=20.77,
p=0.002). SC miR-95 expression is related to serum concentra-
tions of adiponectin (r=0.52, p,0.05), CrP (r=20.59, p,0.05),
and IL-6 (r=20.53, p,0.05).
We identified 11 miRNAs representing 7% of all analyzed
miRNAs, which are significantly related to the morphology of
adipose tissue, including macrophage infiltration, mean and
maximum adipocyte volume (Table 4). Among them, only
miRNA-95 expression was found to be related to adipocyte size
in both fat depots. Omental miRNA-132 (Figure 1A) and SC
miRNA-26b and miRNA-155 expression are significantly related
to the number of macrophages infiltrating the respective fat depot
(Table 4). The strongest relationship between mean omental
adipocyte diameter and microRNA expression was found for
miRNA-198 (Figure 1B, Table 4).
Discussion
It has been recently suggested that miRNA expression
contributes to the regulation of adipose tissue differentiation [9]
metabolic processes linked to obesity and type 2 diabetes [6,10]. A
potential role of miRNAs in fat metabolism is supported by the
finding in Drosophila melanoaster that microRNA-14 suppresses cell
death and is required for normal fat metabolism [18]. It was
Table 1. Anthropometric and metabolic characteristics of the study groups.
NGT (n=9) T2D (n=6) p-Value
Mean6SEM Mean6SEM
Age (years) 6663.3 6762.8 .0.05
BMI (kg/m
2) 28.662.0 31.262.1 .0.05
WHR 0.9860.3 1.260.3 .0.05
Body fat (%) 3062.6 3262.6 .0.05
Visceral fat area (cm
2)1 2 3 68.7 29467.4 ,0.001
Subcutaneous fat area (cm
2)3 9 6 619 387613 .0.05
Visceral/ SC fat area ratio 0.5960.5 0.8760.5 ,0.05
Fasting plasma insulin (pmol/l) 5967.7 26469.9 ,0.001
Fasting plasma glucose (mmol/l) 5.460.6 7.760.9 ,0.001
HbA1c (%) 5.460.4 6.760.8 ,0.001
Glucose infusion rate (mmol ? kg
21 ? min
21)8 2 63.8 2663.3 ,0.001
Total cholesterol (mmol/l) 5.0615 . 9 60.7 ,0.05
HDL cholesterol (mmol/l) 1.060.5 1.160.4 .0.05
LDL cholesterol (mmol/l) 2.861.0 3.660.5 ,0.05
Free fatty acids (mmol) 0.3560.5 0.7060.5 ,0.01
IL-6 (pg/ml) 6.062.4 7.661.5 .0.05
Leptin (pg/ml) 28.164.5 29.463.8 .0.05
Adiponectin (pg/ml) 6.861.9 3.061.2 ,0.01
hsCRP (mmol) 8.9647 . 8 62.3 .0.05
Macrophages in omental fat (%) 4.561.9 14.061.4 ,0.001
Macrophages in SC fat (%) 2.361.4 4.061 .0.05
doi:10.1371/journal.pone.0004699.t001
Table 2. miRNA gene expression differences between






NGT Mean6SEM Mean6SEM Mean6SEM
miR- 20 9.460.7 8.361.0 1.13 0.03
miR -98 9.761.7 8.160.5 1.2 0.04
miR-197 4.360.6 3.660.4 1.2 0.04
miR-331 7.061.4 5.560.5 1.27 0.01
T2D
miR-17-5p 7.460.9 5.861.0 1.27 0.02
miR-27a 7.061.4 4.961.4 1.43 0.03
miR-29b 9.362.4 5.562.0 1.7 0.01
miR-30c 5.461.9 2.961.2 1.86 0.03
miR-126 4.660.7 2.961.2 1.59 0.04
miR-140 7.160.9 4.761.1 1.51 0.007
miR-145 1.060.8 0.260.7 5.0 0.025
miR-182 15.560.9 12.860.9 1.21 0.005
miR-195 6.160.4 4.161.8 1.49 0.03
miR-199a 4.060.7 2.161.4 1.9 0.02
miR-199b 8.361.1 6.161.8 1.36 0.03
miR-335 7.760.7 5.562.2 1.4 0.04
doi:10.1371/journal.pone.0004699.t002
MicroRNA in Adipose Tissue
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suggesting that miRNAs contribute to specific tissue function by
regulating different gene targets [19]. Based on these findings and
the known heterogeneity of different adipose tissue depots [20], we
tested the hypotheses that miRNA expression in human adipose
tissue is fat depot specific and related to parameters of adipose
tissue morphology, obesity and glucose metabolism.
Here, we report that at least 106 different miRNAs are
expressed in paired samples of human visceral and SC adipose
tissue. Although we found significant expression differences in 16
miRNAs between the two depots, there was no miRNA exclusively
expressed in either depot. This result suggests that visceral and SC
adipose tissue are indeed two locations of a developmentally
homogeneous adipose organ. We found significant miRNA
expression differences between omental and SC fat depots. Most
strikingly, all miRNA expression differences were due to
significantly higher expression in omental fat (Table 2). Quanti-
tative miRNA expression differences between the two fat depots
could contribute to the well described differences in function and
gene expression [20] between visceral and SC adipose tissue. On
the other hand, factors including chronic hyperglycemia, altered
adipokine serum profile in obesity and inflammation could alter
miRNA expression in adipose tissue. Supporting this hypothesis,
we found significant miRNA expression pattern differences
between NGT and T2D patients. In addition, some miRNA
levels significantly correlate with parameters of glucose metabo-
lism, circulating marker of inflammation and adipokines.
Our data suggest that expression of miR-17-5p, miR-132, miR-
134, miR-181a, miR-27a, miR-30e, miR-140, miR-147, miR-155,
miR-197, and miR-210 play a role in the link between adipose
tissue dysfunction and the development of obesity associated
disorders including type 2 diabetes. A causal role of miR17-5p and
miR-132 in obesity related impaired insulin sensitivity is suggested
by the result that both miRNAs are significantly related to lower
visceral fat mass, lower circulating parameters of chronic glycemia
as well as improved insulin sensitivity. It needs to be tested,
whether these correlations are due to altered expression of miR17-
5p and miR-132 target genes, related to determination of visceral
fat mass. In this context, there is recent evidence that miRNA-132
regulates expression of the cAMP response element-binding
(CREB) protein, which plays a role in glucose homeostasis
[21,22]. Another miRNA we found to be significantly related to
insulin sensitivity and chronic hyperglycemia is miR-134, which
has been previously described as modulator of stem cell
differentiation [7]. We therefore hypothesize that miR-134 plays
a role in adipocyte differentiation and may contribute to the either
hypertrophic insulin resistant or hyperplastic insulin sensitive
subtype of obesity [23].
However, more sophisticated study designs are necessary to
dissect causal from correlative relationships with miRNA expres-
sion in fat. Another key finding of this study is that ,7% of the
detectable miRNAs are significantly associated with adipocyte size,
suggesting that these miRNAs are involved in the regulation of
Table 3. Significant correlates of miRNA expression.
miR17-5p miR-132 miR-134 miR-181a miR-99a miR-325
Body composition r (p-value) r (p-value) r (p-value) r (p-value) r (p-value) r (p-value)
Visceral fat area 20.580 (p,0.05) 20.729 (p,0.01)
Glucose homeostasis
FPG 20.751 (p,0.001)
FPI 20.624 (p,0.05) 20.545 (p,0.05)
GIR 0.624 (p,0.05) 0.642 (p,0.05) 0.655 (p,0.05)
HbA1c 20.66 (p,0.01) 20.59 (p,0.05) 0.56 (p,0.05)
Lipids and hormones
Total Cholesterol 20.68 (p,0.01) 20.63 (p,0.01)
HDL-Cholesterol 0.56 (p,0.05)
LDL-Cholesterol 20.59 (p,0.05)
Free fatty acids 20.62 (p,0.01)
Leptin 20.64 (p,0.01)
Adiponectin 20.59 (p,0.05)
IL-6 20.56 (p,0.05) 20.6 (p,0.05)
doi:10.1371/journal.pone.0004699.t003
Table 4. Relationships between miRNA expression and
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the target genes of these miRNAs, which might be involved in
determination of adipocyte size. Moreover, significant relation-
ships between the expression of three miRNAs and the number of
macrophages infiltrating adipose tissue suggests that miRNAs play
a role in attracting immune cells to adipose tissue. Since we used
adipose tissue samples, we can not dissect whether adipocytes or
cells of the stromal vascular fraction cause fat depot specific
miRNA expression differences and the described significant
correlations with metabolic parameters. However, it is unlikely
that increased macrophage infiltration itself causes a negative
relationship with the expression of miR-132, -26b, and -155.
Further studies will elucidate target mRNAs of these miRNAs,
which might be causally related to macrophage infiltration into
adipose tissue.
Noteworthy, our study has several limitations. Obviously, the
number of subjects was relatively small and the described
associations between anthropometric and metabolic parameters
and miRNA expression will require confirmation in larger cohorts.
We can also not exclude that specific characteristics of our study
population, i.e. wide range of BMI and glucose tolerance
distribution produced the described significant correlations. After
appropriate adjustment for confounding variables and Bonferroni
correction for multiple comparisons, only relationships with a p-
Figure 1. Relationships between miRNA (miR-132 and miR-198) expression and morphology of adipose tissue. (A) Typical example of
omental adipose tissue morphology demonstrating lower macrophage infiltration in a patient with high miRNA-132 expression (miR-132 high)
compared to a patient with low miRNA-132 expression (miR-132 low). Macrophage infiltration was assessed by immunostaining for CD68 as
described in the methods. Upper slides, magnification 206, lower slides, magnification 106(B) Mean omental adipocyte diameter in a patient with
high miRNA-198 expression (miR-198 high) compared to a patient with low miRNA-198 expression (miR-198 low). Aliquots of adipocytes were fixed
with osmic acid and counted in triplicate using Multisizer III (Beckman-Coulter, Hamburg, Germany).
doi:10.1371/journal.pone.0004699.g001
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ever, raising the threshold for significant results by Bonferroni
correction might lead to discarding some findings which could be
biologically meaningful. To date there is no study on the
relationship of microRNA expression in human subcutaneous
and omental adipose tissue and therefore, we believe it is
necessary to report our findings that may be verified by studies in
larger cohorts. By showing unadjusted p-values, we follow the
view of Kenneth J. Rothman that no adjustments are needed for
multiple comparisons, if the unadjusted P-values are declared as
such, so that the data can be exposed to verification by others
[24]. In addition, there are some difficulties in the interpretation
of miRNA expression data. For example, to investigate biological
functions of miRNAs, it is critical to identify miRNA-directed
target genes. Currently available computational methods (e.g.,
miRanda, PicTar, and TargetScan) predict numerous target
genes that contain many false positives for miRNA [25,26]. Also,
experimental verification of miRNA-target relationship is
complicated by the potential outcome of such an interaction
being either translational repression or degradation. Further-
more, miRNAs can target multiple genes, and thereby the
biological function of a single miRNA can be diverse. Hence, not
only to achieve a higher degree of specificity of the prediction,
but also to comprehensively understand the function of miRNA,
large-scale prediction of targets across a whole genome would be
required [24].
In conclusion, miRNA expression patterns in omental and SC
adipose tissue suggest a common developmental origin of both fat
depots. Differences in miRNA expression might contribute to
differences in adipose tissue biology between omental and
subcutaneous depots. In addition, human adipose tissue miRNA
expression correlates with adipocyte phenotype, parameters of
obesity and glucose metabolism.
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